Inactivation of plasminogen activator inhibitor by oxidants

The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biochemistry (Easton) 1986-10, Vol.25 (21), p.6351-6355
Hauptverfasser: Lawrence, Daniel A, Loskutoff, David J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6355
container_issue 21
container_start_page 6351
container_title Biochemistry (Easton)
container_volume 25
creator Lawrence, Daniel A
Loskutoff, David J
description The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity resulted from the oxidizing conditions employed. In an attempt to further study the nature of this inactivation, the PAI was treated with chloramine T under conditions that specifically oxidize methionine and cysteine residues. Both PAI inhibitory activity and the ability of the PAI to form complexes with tissue-type PA were decreased in a dose-dependent manner by such treatment. The PAI was more sensitive to oxidative inactivation than urokinase, elastase, and alpha 1-protease inhibitor. Incubation of the chloramine T inactivated PAI with methionine sulfoxide peptide reductase in the presence of dithiothreitol (DTT) restored more than 90% of the PAI activity. The reductase is a DTT-dependent enzyme that specifically converts methionine sulfoxide to methionine. Little activity was restored by either the reductase or DTT alone. These results indicate that the oxidation of at least one critical methionine residue is responsible for the loss of PAI activity upon iodination. In this respect, the BAE PAI resembles alpha 1-protease inhibitor, a well-characterized elastase inhibitor that also is inactivated by oxidants. Both inhibitors are members of the serine protease inhibitor superfamily (Serpins), and both have a methionine residue in their reactive center.
doi_str_mv 10.1021/bi00369a001
format Article
fullrecord <record><control><sourceid>proquest_osti_</sourceid><recordid>TN_cdi_proquest_miscellaneous_77201112</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>14737191</sourcerecordid><originalsourceid>FETCH-LOGICAL-a507t-44b5dd8a559ae5bac9dcff64aec46ab232de26d43e6463ff9211beb35d2fdf383</originalsourceid><addsrcrecordid>eNqF0c1rFDEYBvAgSl2rJ8_CIKIHGc33TPAk60cLRYWtIF7Cm0xiU2eTNclK-987ywyLB8FTEp4fLy9PEHpM8CuCKXltAsZMKsCY3EErIihuuVLiLlphjGVLlcT30YNSrqcnxx0_QScMq5723Qq9OY9ga_gNNaTYJN_sRijbENMPF5slSbkJ8SqYcLiZ2ybdhAFiLQ_RPQ9jcY-W8xR9_fD-cn3WXnz-eL5-e9GCwF1tOTdiGHoQQoETBqwarPeSg7NcgqGMDo7KgTMnuWTeK0qIcYaJgfrBs56doqfz3FRq0MWG6uyVTTE6W7UUtOt6OqHnM9rl9GvvStXbUKwbR4gu7YvuOooJIf-HhHesI4pM8OUMbU6lZOf1Loct5FtNsD4Ur_8qftJPlrF7s3XD0S5NT_mzJYdiYfQZog3lyHoqRU8PY9qZhVLdzTGG_FPLaS-hL79sdP_t0-b75uydXk_-xezBFn2d9jlOP_HPBf8AZmOmGw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>14737191</pqid></control><display><type>article</type><title>Inactivation of plasminogen activator inhibitor by oxidants</title><source>MEDLINE</source><source>ACS Publications</source><creator>Lawrence, Daniel A ; Loskutoff, David J</creator><creatorcontrib>Lawrence, Daniel A ; Loskutoff, David J ; Scripps Clinic and Research Foundation, La Jolla, CA</creatorcontrib><description>The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity resulted from the oxidizing conditions employed. In an attempt to further study the nature of this inactivation, the PAI was treated with chloramine T under conditions that specifically oxidize methionine and cysteine residues. Both PAI inhibitory activity and the ability of the PAI to form complexes with tissue-type PA were decreased in a dose-dependent manner by such treatment. The PAI was more sensitive to oxidative inactivation than urokinase, elastase, and alpha 1-protease inhibitor. Incubation of the chloramine T inactivated PAI with methionine sulfoxide peptide reductase in the presence of dithiothreitol (DTT) restored more than 90% of the PAI activity. The reductase is a DTT-dependent enzyme that specifically converts methionine sulfoxide to methionine. Little activity was restored by either the reductase or DTT alone. These results indicate that the oxidation of at least one critical methionine residue is responsible for the loss of PAI activity upon iodination. In this respect, the BAE PAI resembles alpha 1-protease inhibitor, a well-characterized elastase inhibitor that also is inactivated by oxidants. Both inhibitors are members of the serine protease inhibitor superfamily (Serpins), and both have a methionine residue in their reactive center.</description><identifier>ISSN: 0006-2960</identifier><identifier>EISSN: 1520-4995</identifier><identifier>DOI: 10.1021/bi00369a001</identifier><identifier>PMID: 3098287</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>550201 - Biochemistry- Tracer Techniques ; AMINES ; AMINO ACIDS ; ANIMAL TISSUES ; Animals ; aorta ; Aorta - metabolism ; BASIC BIOLOGICAL SCIENCES ; BETA DECAY RADIOISOTOPES ; Biological and medical sciences ; Blood coagulation. Blood cells ; BODY ; CARBOXYLIC ACIDS ; Cattle ; CELL CULTURES ; Cells, Cultured ; CHEMICAL REACTIONS ; chloramine T ; CHLORAMINES ; Chloramines - pharmacology ; COAGULANTS ; DAYS LIVING RADIOISOTOPES ; DECOMPOSITION ; DRUGS ; ELECTRON CAPTURE RADIOISOTOPES ; ENDOTHELIUM ; Endothelium - metabolism ; ENZYMATIC HYDROLYSIS ; ENZYME INHIBITORS ; ENZYMES ; FIBRIN ; FIBRINOLYTIC AGENTS ; Fundamental and applied biological sciences. Psychology ; General aspects, investigation methods, hemostasis, fibrinolysis ; Glycoproteins - antagonists &amp; inhibitors ; Glycoproteins - isolation &amp; purification ; HALOGENATION ; HEMATOLOGIC AGENTS ; HEMOSTATICS ; HYDROLYSIS ; INACTIVATION ; INTERMEDIATE MASS NUCLEI ; IODINATION ; IODINE 125 ; IODINE ISOTOPES ; ISOTOPES ; Kinetics ; LABELLED COMPOUNDS ; LIPOTROPIC FACTORS ; LYSIS ; METHIONINE ; Molecular and cellular biology ; NUCLEI ; ODD-EVEN NUCLEI ; ORGANIC ACIDS ; ORGANIC CHLORINE COMPOUNDS ; ORGANIC COMPOUNDS ; ORGANIC HALOGEN COMPOUNDS ; ORGANIC SULFUR COMPOUNDS ; OXIDATION ; Oxidation-Reduction ; OXIDIZERS ; OXIDOREDUCTASES ; PLASMINOGEN ; plasminogen activator inhibitor ; Plasminogen Activators - antagonists &amp; inhibitors ; Plasminogen Inactivators ; PROTEINS ; RADIOISOTOPES ; SCLEROPROTEINS ; SOLVOLYSIS ; TISSUES ; Tosyl Compounds</subject><ispartof>Biochemistry (Easton), 1986-10, Vol.25 (21), p.6351-6355</ispartof><rights>1987 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a507t-44b5dd8a559ae5bac9dcff64aec46ab232de26d43e6463ff9211beb35d2fdf383</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/bi00369a001$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/bi00369a001$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,885,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=8265821$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3098287$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://www.osti.gov/biblio/6527782$$D View this record in Osti.gov$$Hfree_for_read</backlink></links><search><creatorcontrib>Lawrence, Daniel A</creatorcontrib><creatorcontrib>Loskutoff, David J</creatorcontrib><creatorcontrib>Scripps Clinic and Research Foundation, La Jolla, CA</creatorcontrib><title>Inactivation of plasminogen activator inhibitor by oxidants</title><title>Biochemistry (Easton)</title><addtitle>Biochemistry</addtitle><description>The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity resulted from the oxidizing conditions employed. In an attempt to further study the nature of this inactivation, the PAI was treated with chloramine T under conditions that specifically oxidize methionine and cysteine residues. Both PAI inhibitory activity and the ability of the PAI to form complexes with tissue-type PA were decreased in a dose-dependent manner by such treatment. The PAI was more sensitive to oxidative inactivation than urokinase, elastase, and alpha 1-protease inhibitor. Incubation of the chloramine T inactivated PAI with methionine sulfoxide peptide reductase in the presence of dithiothreitol (DTT) restored more than 90% of the PAI activity. The reductase is a DTT-dependent enzyme that specifically converts methionine sulfoxide to methionine. Little activity was restored by either the reductase or DTT alone. These results indicate that the oxidation of at least one critical methionine residue is responsible for the loss of PAI activity upon iodination. In this respect, the BAE PAI resembles alpha 1-protease inhibitor, a well-characterized elastase inhibitor that also is inactivated by oxidants. Both inhibitors are members of the serine protease inhibitor superfamily (Serpins), and both have a methionine residue in their reactive center.</description><subject>550201 - Biochemistry- Tracer Techniques</subject><subject>AMINES</subject><subject>AMINO ACIDS</subject><subject>ANIMAL TISSUES</subject><subject>Animals</subject><subject>aorta</subject><subject>Aorta - metabolism</subject><subject>BASIC BIOLOGICAL SCIENCES</subject><subject>BETA DECAY RADIOISOTOPES</subject><subject>Biological and medical sciences</subject><subject>Blood coagulation. Blood cells</subject><subject>BODY</subject><subject>CARBOXYLIC ACIDS</subject><subject>Cattle</subject><subject>CELL CULTURES</subject><subject>Cells, Cultured</subject><subject>CHEMICAL REACTIONS</subject><subject>chloramine T</subject><subject>CHLORAMINES</subject><subject>Chloramines - pharmacology</subject><subject>COAGULANTS</subject><subject>DAYS LIVING RADIOISOTOPES</subject><subject>DECOMPOSITION</subject><subject>DRUGS</subject><subject>ELECTRON CAPTURE RADIOISOTOPES</subject><subject>ENDOTHELIUM</subject><subject>Endothelium - metabolism</subject><subject>ENZYMATIC HYDROLYSIS</subject><subject>ENZYME INHIBITORS</subject><subject>ENZYMES</subject><subject>FIBRIN</subject><subject>FIBRINOLYTIC AGENTS</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General aspects, investigation methods, hemostasis, fibrinolysis</subject><subject>Glycoproteins - antagonists &amp; inhibitors</subject><subject>Glycoproteins - isolation &amp; purification</subject><subject>HALOGENATION</subject><subject>HEMATOLOGIC AGENTS</subject><subject>HEMOSTATICS</subject><subject>HYDROLYSIS</subject><subject>INACTIVATION</subject><subject>INTERMEDIATE MASS NUCLEI</subject><subject>IODINATION</subject><subject>IODINE 125</subject><subject>IODINE ISOTOPES</subject><subject>ISOTOPES</subject><subject>Kinetics</subject><subject>LABELLED COMPOUNDS</subject><subject>LIPOTROPIC FACTORS</subject><subject>LYSIS</subject><subject>METHIONINE</subject><subject>Molecular and cellular biology</subject><subject>NUCLEI</subject><subject>ODD-EVEN NUCLEI</subject><subject>ORGANIC ACIDS</subject><subject>ORGANIC CHLORINE COMPOUNDS</subject><subject>ORGANIC COMPOUNDS</subject><subject>ORGANIC HALOGEN COMPOUNDS</subject><subject>ORGANIC SULFUR COMPOUNDS</subject><subject>OXIDATION</subject><subject>Oxidation-Reduction</subject><subject>OXIDIZERS</subject><subject>OXIDOREDUCTASES</subject><subject>PLASMINOGEN</subject><subject>plasminogen activator inhibitor</subject><subject>Plasminogen Activators - antagonists &amp; inhibitors</subject><subject>Plasminogen Inactivators</subject><subject>PROTEINS</subject><subject>RADIOISOTOPES</subject><subject>SCLEROPROTEINS</subject><subject>SOLVOLYSIS</subject><subject>TISSUES</subject><subject>Tosyl Compounds</subject><issn>0006-2960</issn><issn>1520-4995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1986</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c1rFDEYBvAgSl2rJ8_CIKIHGc33TPAk60cLRYWtIF7Cm0xiU2eTNclK-987ywyLB8FTEp4fLy9PEHpM8CuCKXltAsZMKsCY3EErIihuuVLiLlphjGVLlcT30YNSrqcnxx0_QScMq5723Qq9OY9ga_gNNaTYJN_sRijbENMPF5slSbkJ8SqYcLiZ2ybdhAFiLQ_RPQ9jcY-W8xR9_fD-cn3WXnz-eL5-e9GCwF1tOTdiGHoQQoETBqwarPeSg7NcgqGMDo7KgTMnuWTeK0qIcYaJgfrBs56doqfz3FRq0MWG6uyVTTE6W7UUtOt6OqHnM9rl9GvvStXbUKwbR4gu7YvuOooJIf-HhHesI4pM8OUMbU6lZOf1Loct5FtNsD4Ur_8qftJPlrF7s3XD0S5NT_mzJYdiYfQZog3lyHoqRU8PY9qZhVLdzTGG_FPLaS-hL79sdP_t0-b75uydXk_-xezBFn2d9jlOP_HPBf8AZmOmGw</recordid><startdate>19861021</startdate><enddate>19861021</enddate><creator>Lawrence, Daniel A</creator><creator>Loskutoff, David J</creator><general>American Chemical Society</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>C1K</scope><scope>7X8</scope><scope>OTOTI</scope></search><sort><creationdate>19861021</creationdate><title>Inactivation of plasminogen activator inhibitor by oxidants</title><author>Lawrence, Daniel A ; Loskutoff, David J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a507t-44b5dd8a559ae5bac9dcff64aec46ab232de26d43e6463ff9211beb35d2fdf383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1986</creationdate><topic>550201 - Biochemistry- Tracer Techniques</topic><topic>AMINES</topic><topic>AMINO ACIDS</topic><topic>ANIMAL TISSUES</topic><topic>Animals</topic><topic>aorta</topic><topic>Aorta - metabolism</topic><topic>BASIC BIOLOGICAL SCIENCES</topic><topic>BETA DECAY RADIOISOTOPES</topic><topic>Biological and medical sciences</topic><topic>Blood coagulation. Blood cells</topic><topic>BODY</topic><topic>CARBOXYLIC ACIDS</topic><topic>Cattle</topic><topic>CELL CULTURES</topic><topic>Cells, Cultured</topic><topic>CHEMICAL REACTIONS</topic><topic>chloramine T</topic><topic>CHLORAMINES</topic><topic>Chloramines - pharmacology</topic><topic>COAGULANTS</topic><topic>DAYS LIVING RADIOISOTOPES</topic><topic>DECOMPOSITION</topic><topic>DRUGS</topic><topic>ELECTRON CAPTURE RADIOISOTOPES</topic><topic>ENDOTHELIUM</topic><topic>Endothelium - metabolism</topic><topic>ENZYMATIC HYDROLYSIS</topic><topic>ENZYME INHIBITORS</topic><topic>ENZYMES</topic><topic>FIBRIN</topic><topic>FIBRINOLYTIC AGENTS</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General aspects, investigation methods, hemostasis, fibrinolysis</topic><topic>Glycoproteins - antagonists &amp; inhibitors</topic><topic>Glycoproteins - isolation &amp; purification</topic><topic>HALOGENATION</topic><topic>HEMATOLOGIC AGENTS</topic><topic>HEMOSTATICS</topic><topic>HYDROLYSIS</topic><topic>INACTIVATION</topic><topic>INTERMEDIATE MASS NUCLEI</topic><topic>IODINATION</topic><topic>IODINE 125</topic><topic>IODINE ISOTOPES</topic><topic>ISOTOPES</topic><topic>Kinetics</topic><topic>LABELLED COMPOUNDS</topic><topic>LIPOTROPIC FACTORS</topic><topic>LYSIS</topic><topic>METHIONINE</topic><topic>Molecular and cellular biology</topic><topic>NUCLEI</topic><topic>ODD-EVEN NUCLEI</topic><topic>ORGANIC ACIDS</topic><topic>ORGANIC CHLORINE COMPOUNDS</topic><topic>ORGANIC COMPOUNDS</topic><topic>ORGANIC HALOGEN COMPOUNDS</topic><topic>ORGANIC SULFUR COMPOUNDS</topic><topic>OXIDATION</topic><topic>Oxidation-Reduction</topic><topic>OXIDIZERS</topic><topic>OXIDOREDUCTASES</topic><topic>PLASMINOGEN</topic><topic>plasminogen activator inhibitor</topic><topic>Plasminogen Activators - antagonists &amp; inhibitors</topic><topic>Plasminogen Inactivators</topic><topic>PROTEINS</topic><topic>RADIOISOTOPES</topic><topic>SCLEROPROTEINS</topic><topic>SOLVOLYSIS</topic><topic>TISSUES</topic><topic>Tosyl Compounds</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lawrence, Daniel A</creatorcontrib><creatorcontrib>Loskutoff, David J</creatorcontrib><creatorcontrib>Scripps Clinic and Research Foundation, La Jolla, CA</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><collection>OSTI.GOV</collection><jtitle>Biochemistry (Easton)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lawrence, Daniel A</au><au>Loskutoff, David J</au><aucorp>Scripps Clinic and Research Foundation, La Jolla, CA</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inactivation of plasminogen activator inhibitor by oxidants</atitle><jtitle>Biochemistry (Easton)</jtitle><addtitle>Biochemistry</addtitle><date>1986-10-21</date><risdate>1986</risdate><volume>25</volume><issue>21</issue><spage>6351</spage><epage>6355</epage><pages>6351-6355</pages><issn>0006-2960</issn><eissn>1520-4995</eissn><abstract>The rapidly acting plasminogen activator inhibitor (PAI) purified from cultured bovine aortic endothelial cells (BAEs) was inactivated during iodination with chloramine T and other oxidizing iodination systems. Inactivation was observed in the absence of iodine, suggesting that the loss of activity resulted from the oxidizing conditions employed. In an attempt to further study the nature of this inactivation, the PAI was treated with chloramine T under conditions that specifically oxidize methionine and cysteine residues. Both PAI inhibitory activity and the ability of the PAI to form complexes with tissue-type PA were decreased in a dose-dependent manner by such treatment. The PAI was more sensitive to oxidative inactivation than urokinase, elastase, and alpha 1-protease inhibitor. Incubation of the chloramine T inactivated PAI with methionine sulfoxide peptide reductase in the presence of dithiothreitol (DTT) restored more than 90% of the PAI activity. The reductase is a DTT-dependent enzyme that specifically converts methionine sulfoxide to methionine. Little activity was restored by either the reductase or DTT alone. These results indicate that the oxidation of at least one critical methionine residue is responsible for the loss of PAI activity upon iodination. In this respect, the BAE PAI resembles alpha 1-protease inhibitor, a well-characterized elastase inhibitor that also is inactivated by oxidants. Both inhibitors are members of the serine protease inhibitor superfamily (Serpins), and both have a methionine residue in their reactive center.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>3098287</pmid><doi>10.1021/bi00369a001</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0006-2960
ispartof Biochemistry (Easton), 1986-10, Vol.25 (21), p.6351-6355
issn 0006-2960
1520-4995
language eng
recordid cdi_proquest_miscellaneous_77201112
source MEDLINE; ACS Publications
subjects 550201 - Biochemistry- Tracer Techniques
AMINES
AMINO ACIDS
ANIMAL TISSUES
Animals
aorta
Aorta - metabolism
BASIC BIOLOGICAL SCIENCES
BETA DECAY RADIOISOTOPES
Biological and medical sciences
Blood coagulation. Blood cells
BODY
CARBOXYLIC ACIDS
Cattle
CELL CULTURES
Cells, Cultured
CHEMICAL REACTIONS
chloramine T
CHLORAMINES
Chloramines - pharmacology
COAGULANTS
DAYS LIVING RADIOISOTOPES
DECOMPOSITION
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
ENDOTHELIUM
Endothelium - metabolism
ENZYMATIC HYDROLYSIS
ENZYME INHIBITORS
ENZYMES
FIBRIN
FIBRINOLYTIC AGENTS
Fundamental and applied biological sciences. Psychology
General aspects, investigation methods, hemostasis, fibrinolysis
Glycoproteins - antagonists & inhibitors
Glycoproteins - isolation & purification
HALOGENATION
HEMATOLOGIC AGENTS
HEMOSTATICS
HYDROLYSIS
INACTIVATION
INTERMEDIATE MASS NUCLEI
IODINATION
IODINE 125
IODINE ISOTOPES
ISOTOPES
Kinetics
LABELLED COMPOUNDS
LIPOTROPIC FACTORS
LYSIS
METHIONINE
Molecular and cellular biology
NUCLEI
ODD-EVEN NUCLEI
ORGANIC ACIDS
ORGANIC CHLORINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
ORGANIC SULFUR COMPOUNDS
OXIDATION
Oxidation-Reduction
OXIDIZERS
OXIDOREDUCTASES
PLASMINOGEN
plasminogen activator inhibitor
Plasminogen Activators - antagonists & inhibitors
Plasminogen Inactivators
PROTEINS
RADIOISOTOPES
SCLEROPROTEINS
SOLVOLYSIS
TISSUES
Tosyl Compounds
title Inactivation of plasminogen activator inhibitor by oxidants
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T08%3A48%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_osti_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inactivation%20of%20plasminogen%20activator%20inhibitor%20by%20oxidants&rft.jtitle=Biochemistry%20(Easton)&rft.au=Lawrence,%20Daniel%20A&rft.aucorp=Scripps%20Clinic%20and%20Research%20Foundation,%20La%20Jolla,%20CA&rft.date=1986-10-21&rft.volume=25&rft.issue=21&rft.spage=6351&rft.epage=6355&rft.pages=6351-6355&rft.issn=0006-2960&rft.eissn=1520-4995&rft_id=info:doi/10.1021/bi00369a001&rft_dat=%3Cproquest_osti_%3E14737191%3C/proquest_osti_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=14737191&rft_id=info:pmid/3098287&rfr_iscdi=true